In this issue of Blood, Matafonov et al demonstrate that an inhibiting monoclonal antibody against coagulation factor XII (fXII) reduces fibrin formation and platelet accumulation in a primate thrombosis model.
科研之友
微信
新浪微博
Facebook
分享链接
